Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform
Polyrizon Ltd., a biotech company specializing in intranasal hydrogels, announced the submission of amended claims in its U.S. patent application to broaden protection for its proprietary intranasal drug delivery platform. The expanded claims now cover drug delivery systems and methods of use designed to improve drug residence time and absorption i…